Shopping Cart
Remove All
Your shopping cart is currently empty
Azintuxizumab vedotin
Copy Product Info
😃Good
Catalog No. T9901A-036Cas No. 1826819-58-2
Alias ABBV-838
Azintuxizumab vedotin (ABBV-838) is an antibody-drug conjugate (ADC) that targets a specific epitope of CD2 subset 1, a cell-surface glycoprotein found on multiple myeloma cells [1].
Azintuxizumab vedotin
Azintuxizumab vedotin
Copy Product Info😃Good
Purity: 95%
Catalog No. T9901A-036Alias ABBV-838Cas No. 1826819-58-2
Azintuxizumab vedotin (ABBV-838) is an antibody-drug conjugate (ADC) that targets a specific epitope of CD2 subset 1, a cell-surface glycoprotein found on multiple myeloma cells [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $415 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $1,230 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,990 | 2-4 weeks | 2-4 weeks |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Antigen Details
Chemical Properties
Storage & Solubility Information
| Description | Azintuxizumab vedotin (ABBV-838) is an antibody-drug conjugate (ADC) that targets a specific epitope of CD2 subset 1, a cell-surface glycoprotein found on multiple myeloma cells [1]. |
| In vitro | Azintuxizumab vedotin (ABBV-838) is an antibody-drug conjugate (ADC) composed of a humanized recombinant immunoglobulin G1κ targeting a unique epitope of CD2 subset 1 (CS1, also known as SLAMF7). It is linked to the cytotoxic agent monomethyl auristatin E (MMAE) via a valine-citrulline linker, demonstrating potent cytotoxic activity against CS1-expressing cancer cells [1]. |
| In vivo | Azintuxizumab vedotin (ABBV-838) demonstrated single-agent antitumor activity in a mouse model xenografted with human multiple myeloma [1]. |
| Synonyms | ABBV-838 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Target | CD2 |
| Cas No. | 1826819-58-2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Azintuxizumab vedotin | purchase Azintuxizumab vedotin | Azintuxizumab vedotin cost | order Azintuxizumab vedotin | Azintuxizumab vedotin in vivo | Azintuxizumab vedotin in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.